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Hyper-reactivity, inflammation and hyperplasia/hypertrophy of airway smooth muscle (ASM) 
limit airflow and are key features of chronic obstructive pulmonary disease (COPD). Proteinase 
activated receptor 2 (PAR2) is a critical modulator of inflammatory responses in respiratory 
disease such as asthma, yet is reported to promote ASM relaxation. However, the role of ASM 
PAR2 in COPD is not well understood1. 
Our aim was to determine the presence and role of PAR2 in murine lung and ASM subjected 
to oxidative stress using both immunohistochemistry (IHC) and wire myography.  
PAR2 was detected using APR-32 antibody (Alomone, Israel) on both murine airway and lung 
tissue, with clean isotype. 
Oxidative stress increased trypsin-induced ASM relaxation in both bronchial and tracheal 
tissue. This was PAR2 dependent, as relaxation was significantly reduced in PAR2-/- compared 
with WT tracheal (mean ± SEM; WT 53.4±13.4 % vs. PAR2-/- 2.5±0.8 %; p=0.02; n=3-4) and 
bronchial tissue (WT 56±13.3 % vs. PAR2-/- 2.3± 0.9 %; p=0.02; n=3-4).   
In conclusion, this study confirms a functional PAR2 role in murine airway tissue; importantly, 
the role of PAR2 in mediating ASM relaxation appears to be enhanced in oxidative 
environments such as found in COPD.  This may have important implications for future 
potential therapies.  
1. Sokolova E, Reiser G. A novel therapeutic target in various lung diseases: Airway 
proteases and protease-activated receptors. Pharmacol Ther. 2007;115(1):70–83. 
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